ArticleSisli Etfal Hastanesi tip bulteni2026
Effects of Phototherapy on Sleep, Fatigue and Quality of Life in Dermatology Patients: A Pilot Study.
Article in Sisli Etfal Hastanesi tip bulteni, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Sleep disturbances and fatigue are prevalent among dermatology patients. Owing to the growing evidence on the effects of light-based therapies on neuropsychiatric disorders, this study aimed to investigate how narrow-band ultraviolet B (NB-UVB) phototherapy influences sleep quality and fatigue. Methods: In this prospective observational study, 30 patients receiving or scheduled to receive NB-UVB phototherapy were included. Phototherapy was administered 2-3 times per week with eye protection. Sleep quality, fatigue, and dermatology-specific quality of life were assessed using the Pittsburgh Sleep Quality Index (PSQI), Piper Fatigue Scale (PFS), and Dermatology Life Quality Index (DLQI), respectively. Measurements were performed at study entry and at the one-month follow-up. Results: The mean age was 48.2±12.9 years, and 63.3% of the patients were male. The most common diagnoses were vitiligo (40%), mycosis fungoides (26.7%), and psoriasis vulgaris (13.3%). The median PSQI score decreased from 8 at baseline to 5 at the one-month follow-up (p<0.001). The median PFS score decreased from 3.88 to 2.38 (p=0.019). DLQI showed no significant change. Changes in PSQI and PFS were significantly correlated (r=0.435, p=0.016). Multiple regression analysis identified ΔPFS, total cumulative dose, and ΔDLQI as independent predictors of ΔPSQI. Conclusion: NB-UVB phototherapy was associated with improvements in sleep quality and fatigue in dermatology patients over the course of treatment. These effects appear to be independent of changes in dermatology-specific quality of life and are likely mediated through neuroendocrine, circadian, and peripheral pathways. NB-UVB phototherapy may serve as an effective adjunctive treatment for sleep disturbances and fatigue in dermatology patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.